Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Patients Treated With Aromatase Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05501886
What this trial is testing

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

Who this might be right for
Breast Cancer
Celcuity Inc 701
Not applicableWithdrawnNCT01714128
What this trial is testing

FES-PET for Patients Treated on NCI Protocol 8762

Who this might be right for
Breast Cancer
Washington University School of Medicine
Not applicableActive Not RecruitingNCT04597580
What this trial is testing

Personalised Disease Monitoring in Metastatic Breast Cancer

Who this might be right for
Breast Cancer MetastaticEstrogen Receptor-positive Breast Cancer
The Christie NHS Foundation Trust 97
Testing effectiveness (Phase 2)Study completedNCT01160718
What this trial is testing

Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Swiss Cancer Institute 46
Large-scale testing (Phase 3)Active Not RecruitingNCT05952557
What this trial is testing

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Who this might be right for
Breast Cancer, Early Breast Cancer
AstraZeneca 5,511
Not applicableEnded earlyNCT04396626
What this trial is testing

HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes

Who this might be right for
Breast Cancer
Pfizer 975
Large-scale testing (Phase 3)Study completedNCT01573442
What this trial is testing

Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment

Who this might be right for
ArthralgiaBreast CancerHot Flashes+2 more
Alliance for Clinical Trials in Oncology 227
Testing effectiveness (Phase 2)Ended earlyNCT01921296
What this trial is testing

Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients

Who this might be right for
Sleep Initiation and Maintenance DisordersPain
Lynn Henry 2
Large-scale testing (Phase 3)Study completedNCT00556374
What this trial is testing

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Amgen 3,420
Testing effectiveness (Phase 2)Study completedNCT02958852
What this trial is testing

A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Lund University Hospital 126
Testing effectiveness (Phase 2)UnknownNCT04942899
What this trial is testing

Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer

Who this might be right for
Metastasis Breast
Assiut University 70
Not applicableStudy completedNCT01384838
What this trial is testing

Exercise Training in Postmenopausal Patients With Breast Cancer

Who this might be right for
Physical Activity
Arbeitsgemeinschaft medikamentoese Tumortherapie 80
Testing effectiveness (Phase 2)Ended earlyNCT00892268
What this trial is testing

Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint Pain

Who this might be right for
Breast CancerMenopausal SymptomsPain
University of Arizona 68
Not applicableStudy completedNCT04394247
What this trial is testing

Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy

Who this might be right for
Breast Cancer
Pfizer 242
Not applicableStudy completedNCT00523315
What this trial is testing

APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)

Who this might be right for
Breast Cancer
AstraZeneca 862
Large-scale testing (Phase 3)Ended earlyNCT05128773
What this trial is testing

Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity

Who this might be right for
Breast Cancer
Sanofi 3
Not applicableStudy completedNCT06307457
What this trial is testing

HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.

Who this might be right for
Breast Cancer
Pfizer 604
Large-scale testing (Phase 3)WithdrawnNCT03740945
What this trial is testing

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

Who this might be right for
Vaginal Atrophy in Breast Cancer Patients
EndoCeutics Inc.
Not applicableStudy completedNCT02524548
What this trial is testing

SMS Reminders to Improve Medication Adherence of Aromatase Inhibitors

Who this might be right for
Breast CancerMedication Adherence
National University of Singapore 244
Post-approval studies (Phase 4)Not Yet RecruitingNCT07630948
What this trial is testing

Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer

Who this might be right for
Breast CancerAdherence, Medication
Institute of Oncology Ljubljana 90
Next Page